Login Register Cart 0
Generic placeholder image

Coronaviruses

Editor-in-Chief

ISSN (Print): 2666-7967
ISSN (Online): 2666-7975

Back
Journal Home About Journal Editorial Board Current Issue Volumes/Issues
Subscribe
Letter to the Editor

The Genomes of SARS-CoV-2 and Related Coronaviruses: Are Accessory Proteins Key for Pathogenesis?

Author(s): Saikat Samanta and Rudra Prasad Saha*

Volume 2, Issue 7, 2021

Published on: 09 December, 2020

Article ID: e250621188925 Pages: 3

DOI: 10.2174/2666796701999201209143320

Abstract

Objective: In January 2020, scientists deciphered the first genome of SARS-CoV-2 that has created a ravage in the world by infecting over 30 million people worldwide with above 0.95 million deaths as of mid-September 2020. With no potent therapeutics against COVID-19, researchers around the world are relentlessly working for the development of a vaccine that can ease the pain the world is suffering today, both in terms of economic and psychological instability. Understanding the genome of SARS-CoV-2 is essential to decipher the keys that would help scientists to develop drugs or vaccines to prevent the disease.

Methods: Coronaviruses are not unknown to the human as other than SARS-CoV-2, at least six additional coronaviruses (SARS-CoV, MERS-CoV, HCoV-229E, HCoV-NL63, HCoV-OC43, and HCoV-HKU1) are known that causes mild to severe diseases in human. We have compared the sequences of these seven coronaviruses to identify the key regions which are responsible for pathogenesis.

Results: The genomes of the seven coronaviruses that are known to infect humans differ significantly, especially in the regions of accessory genes.

Conclusion: The analysis of these virus genomes is the key to find out targets for the development of a potent drug or vaccine against COVID-19.

Keywords: SARS-CoV-2, COVID-19, coronavirus, vaccine development, accessory proteins, pathogenesis.

[1]
Wu F, Zhao S, Yu B, et al. A new coronavirus associated with human respiratory disease in China. Nature 2020; 579(7798): 265-9.
[http://dx.doi.org/10.1038/s41586-020-2008-3] [PMID: 32015508]
[2]
Chen Y, Liu Q, Guo D. Emerging coronaviruses: Genome structure, replication, and pathogenesis. J Med Virol 2020; 92(4): 418-23.
[http://dx.doi.org/10.1002/jmv.25681] [PMID: 31967327]
[3]
Thiel V, Herold J, Schelle B, Siddell SG. Infectious RNA transcribed in vitro from a cDNA copy of the human coronavirus genome cloned in vaccinia virus. J Gen Virol 2001; 82(Pt 6): 1273-81.
[http://dx.doi.org/10.1099/0022-1317-82-6-1273] [PMID: 11369870]
[4]
Marra MA, Jones SJ, Astell CR, et al. The Genome sequence of the SARS-associated coronavirus. Science 2003; 300(5624): 1399-404.
[http://dx.doi.org/10.1126/science.1085953] [PMID: 12730501]
[5]
van der Hoek L, Pyrc K, Jebbink MF, et al. Identification of a new human coronavirus. Nat Med 2004; 10(4): 368-73.
[http://dx.doi.org/10.1038/nm1024] [PMID: 15034574]
[6]
St-Jean JR, Jacomy H, Desforges M, Vabret A, Freymuth F, Talbot PJ. Human respiratory coronavirus OC43: genetic stability and neuroinvasion. J Virol 2004; 78(16): 8824-34.
[http://dx.doi.org/10.1128/JVI.78.16.8824-8834.2004] [PMID: 15280490]
[7]
Woo PC, Lau SK, Chu CM, et al. Characterization and complete genome sequence of a novel coronavirus, coronavirus HKU1, from patients with pneumonia. J Virol 2005; 79(2): 884-95.
[http://dx.doi.org/10.1128/JVI.79.2.884-895.2005] [PMID: 15613317]
[8]
van Boheemen S, de Graaf M, Lauber C, et al. Genomic characterization of a newly discovered coronavirus associated with acute respiratory distress syndrome in humans. MBio 2012; 3(6): e00473-12.
[http://dx.doi.org/10.1128/mBio.00473-12] [PMID: 23170002]
[9]
Menachery VD, Mitchell HD, Cockrell AS, et al. MERS-CoV Accessory ORFs play key role for infection and pathogenesis. MBio 2017; 8(4): e00665-17.
[http://dx.doi.org/10.1128/mBio.00665-17] [PMID: 28830941]
[10]
Gordon DE, Jang GM, Bouhaddou M, et al. A SARS-CoV-2 protein interaction map reveals targets for drug repurposing. Nature 2020; 583(7816): 459-68.
[http://dx.doi.org/10.1038/s41586-020-2286-9] [PMID: 32353859]
[11]
Chakraborty C, Sharma AR, Sharma G, Bhattacharya M, Saha RP, Lee SS. Extensive partnership, collaboration, and teamwork is required to stop the COVID-19 outbreak. Arch Med Res 2020; 51(7): 728-30.
[http://dx.doi.org/10.1016/j.arcmed.2020.05.021] [PMID: 32532523]

Rights & Permissions Print Cite
Article Metrics
18
2
1
© 2024 Bentham Science Publishers | Privacy Policy